FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2544705514> ?p ?o ?g. }

• W2544705514 endingPage "947" @default.
• W2544705514 startingPage "940" @default.
• W2544705514 abstract "BACKGROUND The National Surgical Adjuvant Breast and Bowel Project B35 and International Breast Cancer Intervention Studies II Ductal Carcinoma In Situ trials showed similar treatment effects of anastrozole and tamoxifen in reducing cancer recurrence risk among ductal carcinoma in situ (DCIS) patients. Studies have shown low levels of hormone therapy drug initiation for DCIS patients, but the current body of literature lacks information on the 5‐year adherence rates for these drugs from population‐based studies. METHODS This study evaluated the initiation and 5‐year adherence levels for women aged 66 to 85 years who had been diagnosed with estrogen receptor (ER)–positive DCIS between 2007 and 2011 according to the Surveillance, Epidemiology, and End Results and Texas Cancer Registry databases linked to Medicare claims. Chi‐square tests, trend tests, and logistic regression were used to identify factors associated with treatment initiation. RESULTS There were 2871 women with ER‐positive DCIS, and approximately 45% began treatment with tamoxifen or aromatase inhibitors (AIs) within 1 year of their DCIS diagnosis. The median age was 73 years for the users and 75 years for the nonusers. Women aged 66 to 70 years who underwent lumpectomy and radiation therapy were significantly more likely to initiate hormone therapy. The initiation of therapy was also significantly associated with patients' geographic location, education, marital status, diagnosis year, and race/ethnicity. Among users, adherence decreased from 67% in the first year to 30% in the fifth year. CONCLUSIONS Initiation and adherence levels for tamoxifen or AIs among older women with ER‐positive DCIS are low. Future studies should develop methods to ensure that informed discussions take place between health care providers and patients regarding hormonal therapy for cancer prevention. Cancer 2017;123:940–47. © 2016 American Cancer Society ." @default.
• W2544705514 created "2016-11-04" @default.
• W2544705514 creator A5018142325 @default.
• W2544705514 creator A5027028437 @default.
• W2544705514 creator A5029836689 @default.
• W2544705514 creator A5032434478 @default.
• W2544705514 creator A5034465643 @default.
• W2544705514 creator A5039722353 @default.
• W2544705514 creator A5059063695 @default.
• W2544705514 creator A5084054222 @default.
• W2544705514 creator A5084454043 @default.
• W2544705514 date "2016-10-25" @default.
• W2544705514 modified "2023-10-18" @default.
• W2544705514 title "Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ" @default.
• W2544705514 cites W1990582579 @default.
• W2544705514 cites W2000445173 @default.
• W2544705514 cites W2050757566 @default.
• W2544705514 cites W2099163810 @default.
• W2544705514 cites W2103414003 @default.
• W2544705514 cites W2110712889 @default.
• W2544705514 cites W2121656289 @default.
• W2544705514 cites W2122206810 @default.
• W2544705514 cites W2138401856 @default.
• W2544705514 cites W2142753818 @default.
• W2544705514 cites W2157358083 @default.
• W2544705514 cites W2189712549 @default.
• W2544705514 cites W2191470295 @default.
• W2544705514 cites W2191739491 @default.
• W2544705514 cites W2233395388 @default.
• W2544705514 cites W983929512 @default.
• W2544705514 doi "https://doi.org/10.1002/cncr.30425" @default.
• W2544705514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5339027" @default.
• W2544705514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27780311" @default.
• W2544705514 hasPublicationYear "2016" @default.
• W2544705514 type Work @default.
• W2544705514 sameAs 2544705514 @default.
• W2544705514 citedByCount "21" @default.
• W2544705514 countsByYear W25447055142017 @default.
• W2544705514 countsByYear W25447055142018 @default.
• W2544705514 countsByYear W25447055142019 @default.
• W2544705514 countsByYear W25447055142020 @default.
• W2544705514 countsByYear W25447055142021 @default.
• W2544705514 countsByYear W25447055142022 @default.
• W2544705514 countsByYear W25447055142023 @default.
• W2544705514 crossrefType "journal-article" @default.
• W2544705514 hasAuthorship W2544705514A5018142325 @default.
• W2544705514 hasAuthorship W2544705514A5027028437 @default.
• W2544705514 hasAuthorship W2544705514A5029836689 @default.
• W2544705514 hasAuthorship W2544705514A5032434478 @default.
• W2544705514 hasAuthorship W2544705514A5034465643 @default.
• W2544705514 hasAuthorship W2544705514A5039722353 @default.
• W2544705514 hasAuthorship W2544705514A5059063695 @default.
• W2544705514 hasAuthorship W2544705514A5084054222 @default.
• W2544705514 hasAuthorship W2544705514A5084454043 @default.
• W2544705514 hasBestOaLocation W25447055141 @default.
• W2544705514 hasConcept C121608353 @default.
• W2544705514 hasConcept C126322002 @default.
• W2544705514 hasConcept C143998085 @default.
• W2544705514 hasConcept C2775860665 @default.
• W2544705514 hasConcept C2776215463 @default.
• W2544705514 hasConcept C2777176818 @default.
• W2544705514 hasConcept C2777757722 @default.
• W2544705514 hasConcept C2778311097 @default.
• W2544705514 hasConcept C2778504769 @default.
• W2544705514 hasConcept C2779572924 @default.
• W2544705514 hasConcept C2780275930 @default.
• W2544705514 hasConcept C2780862961 @default.
• W2544705514 hasConcept C2908647359 @default.
• W2544705514 hasConcept C29456083 @default.
• W2544705514 hasConcept C530470458 @default.
• W2544705514 hasConcept C71924100 @default.
• W2544705514 hasConcept C99454951 @default.
• W2544705514 hasConceptScore W2544705514C121608353 @default.
• W2544705514 hasConceptScore W2544705514C126322002 @default.
• W2544705514 hasConceptScore W2544705514C143998085 @default.
• W2544705514 hasConceptScore W2544705514C2775860665 @default.
• W2544705514 hasConceptScore W2544705514C2776215463 @default.
• W2544705514 hasConceptScore W2544705514C2777176818 @default.
• W2544705514 hasConceptScore W2544705514C2777757722 @default.
• W2544705514 hasConceptScore W2544705514C2778311097 @default.
• W2544705514 hasConceptScore W2544705514C2778504769 @default.
• W2544705514 hasConceptScore W2544705514C2779572924 @default.
• W2544705514 hasConceptScore W2544705514C2780275930 @default.
• W2544705514 hasConceptScore W2544705514C2780862961 @default.
• W2544705514 hasConceptScore W2544705514C2908647359 @default.
• W2544705514 hasConceptScore W2544705514C29456083 @default.
• W2544705514 hasConceptScore W2544705514C530470458 @default.
• W2544705514 hasConceptScore W2544705514C71924100 @default.
• W2544705514 hasConceptScore W2544705514C99454951 @default.
• W2544705514 hasFunder F4320309682 @default.
• W2544705514 hasFunder F4320337351 @default.
• W2544705514 hasIssue "6" @default.
• W2544705514 hasLocation W25447055141 @default.
• W2544705514 hasLocation W25447055142 @default.
• W2544705514 hasLocation W25447055143 @default.
• W2544705514 hasLocation W25447055144 @default.
• W2544705514 hasOpenAccess W2544705514 @default.
• W2544705514 hasPrimaryLocation W25447055141 @default.

• next